The Spinal Cord Independence Measure (SCIM) version III:: Reliability and validity in a multi-center international study

The Spinal Cord Independence Measure (SCIM) version III:: Reliability and validity in a multi-center international study
复制标题

DOI:
10.1080/09638280601046302
复制
发表时间:
2007-01-01
影响因子:
2.2
通讯作者:
Catz, A.
Catz, A.
中科院分区:
医学3区
文献类型:
--
作者:
Itzkovich, M.;Gelernter, I.;Catz, A.

文献摘要

被引文献

相似文献

目的。在一项多中心队列研究中检验第三版脊髓独立性测量(SCIM III)的信度和效度。来自三大洲6个国家13个脊髓单位的425例脊髓病变患者在入院康复和出院前采用SCIM III和功能独立性测量(FIM)进行评估。在大多数SCIM III任务中,评分者之间的总一致性在80%以上,所有kappa系数均具有统计学意义(P < 0.001)。配对评分者的Pearson相关系数均在0.9以上,类内相关系数均在0.94以上。Cronbach’s alpha大于0.7。FIM与SCIM的Pearson相关系数为0.790 (P < 0.01)。SCIM III比FIM对呼吸、括约肌管理和室内外活动亚量表的变化更敏感。研究结果支持SCIM量表在多元文化背景下的信度和效度。尽管该研究存在一些局限性,但结果表明,SCIM III是一种有效的评估SCL患者功能的方法,可以安全地用于临床和研究试验,包括国际多中心研究。
Purpose. To examine the third version of the Spinal Cord Independence Measure (SCIM III) for reliability and validity in a multi-center cohort study.Method. Four hundred and twenty-five patients with spinal cord lesions from 13 spinal cord units in six countries from three continents were assessed with SCIM III and the Functional Independence measure (FIM) on admission to rehabilitation and before discharge.Results. Total agreement between raters was above 80% in most SCIM III tasks, and all kappa coefficients were statistically significant ( P < 0.001). The coefficients of Pearson correlation between the paired raters were above 0.9, and intraclass correlation coefficients were above 0.94. Cronbach's alpha was above 0.7. The coefficient of Pearson correlation between FIM and SCIM III was 0.790 (P < 0.01). SCIM III was more responsive to changes than FIM in the subscales of Respiration and sphincter management and Mobility indoors and outdoors.Conclusions. The results support the reliability and validity of SCIM III in a multi-cultural setup. Despite several limitations of the study, the results indicate that SCIM III is an efficient measure for functional assessment of SCL patients and can be safely used for clinical and research trials, including international multi-center studies.